Chikungunya: first steps toward specific treatment and prophylaxis

Journal of Infectious Diseases

Volumn 200, Issue 4, 2009, Pages 489-491

  Michault, Alain ^a,b   Staikowsky, F ^a,b  

^a Centre Hospitalier Régional   (France)

^b La Réunion ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CHIKUNGUNYA ALPHAVIRUS VACCINE; CHLOROQUINE; CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN G; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE; ANTIVIRUS AGENT;

AEDES AEGYPTI; ARTHRALGIA; CHIKUNGUNYA ALPHAVIRUS; CHIKUNGUNYA INFECTION; COMORBIDITY; DISEASE CARRIER; EPIDEMIC; FEVER; HUMAN; IMMUNOTHERAPY; NEUROLOGIC DISEASE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROPHYLAXIS; RASH; VACCINATION; VERTICAL TRANSMISSION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION; AEDES; ANIMAL; VIROLOGY;

AEDES; ALPHAVIRUS INFECTIONS; ANIMALS; ANTIVIRAL AGENTS; CHIKUNGUNYA VIRUS; HUMANS; INSECT VECTORS;

EID: 69149096241     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/600382     Document Type: Note

References (32)

1. Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-1953.1. Clinical features. Trans R Soc Trop Med Hyg 1955;49:28-32.
2. 2.SangRC,AhmedO,FayeO,etal. EntomologieinvestigationsofaChikungunyavirusepidemicintheUnionoftheComoros,2005. AmJTropMedHyg2008;78:77-82.(Pubitemid351844499)
3. Gerardin P, Guernier V, Perrau J, et al. Estimating Chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis 2008; 8:99.
4. Kariuki Njenga M, Nderitu L, Ledermann JP, et al. Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J Gen Virol 2008;89:2754-2760
5. Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of Chikungunya and O'nyongnyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 2000;81:471-479
6. 6. Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006; 3:e263. (Pubitemid 44125992)
7. Delatte H, Paupy Q Dehecq JS, Thiria J, Failloux AB, Fontenille D. Aedes albopictus, vector of Chikungunya and dengue viruses in Reunion Island: biology and control [in French]. Parasite 2008; 15:3-13.
8. Vazeille M, Moutailler S, Coudrier D, et al. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS ONE 2007;2:e1168.
9. Dash PK, Parida MM, Santhosh SR, et al. East Central South African genotype as the causative agent in reemergence of Chikungunya outbreak in India. Vector Borne Zoonotic Dis 2007;7:519-527
10. Kumar NP, Joseph R, Kamaraj T, Jambulingam P. A226V mutation in virus during the 2007 Chikungunya outbreak in Kerala, India. J Gen Virol 2008;89:1945-1948
11. Santhosh SR, Dash PK, Parida MM, Khan M, Tiwari M, Lakshmana Rao PV Comparative full genome analysis revealed El: A226V shift in 2007 Indian Chikungunya virus isolates. Virus Res 2008; 135:36-41.
12. Simon F, Savini H, Parola P. Chikungunya: a paradigm of emergence and globalization of vector-borne diseases. Med Clin North Am 2008;92:1323-43, ix.
13. Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with Chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 2008; 47: 469-475
14. Toumebize P, Charlin C, Lagrange M. Neurological manifestations in Chikungunya: about 23 cases collected in Reunion Island [in French], Rev Neurol (Paris) 2009; 165: 48-51.
15. Lemant J, Boisson V, Winer A, et al. Serious acute Chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. Crit Care Med 2008; 36: 2536-2541
16. 16. Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of Chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007; 44:1401-1407 (Pubitemid 46801580)
17. Economopoulou A, Dominguez M, Helynck B, et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Reunion. Epidemiol Infect 2009; 137:534-541
18. Staikowsky F, Le Roux K, Schuffenecker I, et al. Retrospective survey of Chikungunya disease in Reunion Island hospital staff. Epidemiol Infect 2008; 136:196-206.
19. Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis: an open pilot study. S Afr Med J 1984; 66:217-218
20. De Lamballerie X, Boisson V, Reynier JC, et al. On Chikungunya acute infection and chloroquine treatment. Vector Borne Zoonotic Dis 2008;8:837-839
21. Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res 2004;61:111-117
22. de Lamballerie X, Ninove L, Charrel RN. Antiviral treatment of Chikungunya virus infection. Infect Disord Drug Targets 2009; 9: 101-104
23. Harrison VR, Binn LN, Randall R. Comparative immunogenicities of Chikungunya vac cines prepared in avian and mammalian tissues. Am J Trop Med Hyg 1967; 16:786-791
24. White A, Berman S, Lowenthal JP. Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures. Appl Microbiol 1972;23:951-952
25. Eckels KH, Harrison VR, Hetrick FM. Chikungunya virus vaccine prepared by Tweenether extraction. Appl Microbiol 1970; 19: 321-325
26. 26.EdelmanR,TacketCO,WassermanSS,BodisonSA,PerryJG,MangiaficoJA. PhaseIIsafetyandimmunogenicitystudyofliveChikungunyavirusvaccineTSI-GSD-218. AmJTropMedHyg2000;62:681-685(Pubitemid32281485)
27. Wang E, Volkova E, Adams AP, et al. Chimeric alphavirus vaccine candidates for Chikungunya. Vaccine 2008; 26:5030-5039
28. Muthumani K, Lankaraman KM, Laddy DJ, et al. Immunogenicity of novel consensusbased DNA vaccines against Chikungunya virus. Vaccine 2008;26:5128-5134
29. Tiwari M, Parida M, Santhosh SR, Khan M, Dash PK, Rao PV Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus. Vaccine 2009;27:2513-2522
30. Couderc T, Khandoudi N, Grandadam M, et al. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 2009;200:515-522 (in this issue).
31. 31. Couderc T, Chretien F, Schilte Q et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008;4:e29. (Pubitemid 351340700)
32. 32. Laurent P, Le Roux K, Grivard P, et al. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify Chikungunya virus. Clin Chem 2007;53:1408-1414 (Pubitemid 47214396)